Physician profile
Karla Hanson
NPI 1023476272
$710.98
in general payments reported to CMS, 2019-2025
10 companies · $127 in 2025
The $127 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $217 · 2022: $124 · 2023: $98.02 · 2024: $145 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $369.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $332.57 | 2021-2025 | Grafix Pl, Grafix, Collagenase Santyl |
| Kerecis Limited | $115.63 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Surgiclose |
| Reprise Biomedical, INC. | $59.12 | 2025 | Miro3d |
| Paratek Pharmaceuticals, INC. | $57.39 | 2021-2024 | Nuzyra |
| Hartmann USA, INC. | $52.75 | 2025 | Zetuvit Plus 10x10 P10 |
| Medline Industries LP | $26.06 | 2023 | |
| Convatec INC. | $17.73 | 2022 | |
| Kci USA, INC. | $16.75 | 2023 | Activ.A.C., 3m Coban |
| Melinta Therapeutics, LLC | $16.65 | 2022 | |
| Solventum Corporation | $16.33 | 2024 | Activ.A.C., Promogran Prisma, 3m Coban |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karla Hanson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.